AARTIDRUGSNSEAarti Drugs Limited· PharmaceuticalsLowNeutral
Announced Mon, 21 Jul · 18:55 IST

Aarti Drugs Limited has informed the Exchange about Link of Recording

Investor Communications View source PDF

AARTIDRUGS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Aarti Drugs has informed the exchanges that the audio recording of its investor and analyst conference call (held on July 15, 2025) to discuss Q1 FY26 financial results has been uploaded to the company's website. The company also mentioned that the written transcript of the call will be shared with the stock exchanges and posted on the website in due course. This is a routine compliance filing under SEBI's Listing Regulations and does not contain any new financial data or guidance. Investors who want to hear management's commentary on the quarter's performance can access the recording via the provided link.

Likely market impact

No direct impact on the stock price or shareholders — this is a procedural disclosure. Investors should listen to the call or wait for the transcript to get management's views on Q1 performance, outlook, and any forward-looking commentary.